CHOLIC ACID

SynDRA canonical compound SYN0006174 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · Rx/OTC
Primary target(s)	PLA2G1B
Mechanism of action	Bile acid
Indication	bile acid synthesis disorders \| peroxisomal disorders \| Zellweger syndrome
Disease area	gastroenterology \| genetics \| neurology/psychiatry

All known targets

orphacol
cholalic acid
cholalin
colalin
kolbam
cholbam
E1000
Cholalic acid
NSC-6135
Cholbam
Kolbam
Orphacol
cholate
Cholalin
Colalin
Cholsaeure
Cholic acid, 5beta-
3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanic acid
3alpha,7alpha,12alpha-Trihydroxy-5beta-cholan-24-oic acid
UNII-G1JO7801AE
HSDB 982
(R)-4-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-Trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid
Cholic acid [USAN]
3,7,12-Trihydroxycholanic acid
G1JO7801AE
CHEMBL205596
CHEBI:16359
NSC6135
BHQCQFFYRZLCQQ-OELDTZBJSA-N
cholic-acid
cholic acid (usp-rs)
ursodeoxycholic acid impurity b (ep impurity)
cholic acid (ep impurity)
cholicacid
3-alpha,7-alpha,12-alpha-Trihydroxycholansaeure
RefChem:54816
DTXCID4020660